ALLEGRA HIVES Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Allegra Hives, and when can generic versions of Allegra Hives launch?
Allegra Hives is a drug marketed by Chattem Sanofi and is included in one NDA.
The generic ingredient in ALLEGRA HIVES is fexofenadine hydrochloride. There are twenty-three drug master file entries for this compound. One hundred and four suppliers are listed for this compound. Additional details are available on the fexofenadine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Allegra Hives
A generic version of ALLEGRA HIVES was approved as fexofenadine hydrochloride by TEVA on September 1st, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ALLEGRA HIVES?
- What are the global sales for ALLEGRA HIVES?
- What is Average Wholesale Price for ALLEGRA HIVES?
Summary for ALLEGRA HIVES
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 127 |
Clinical Trials: | 35 |
Patent Applications: | 1,698 |
DailyMed Link: | ALLEGRA HIVES at DailyMed |
Recent Clinical Trials for ALLEGRA HIVES
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of California, San Francisco | Early Phase 1 |
Food and Drug Administration (FDA) | Early Phase 1 |
University of Alabama at Birmingham | Phase 2 |
Pharmacology for ALLEGRA HIVES
Drug Class | Histamine-1 Receptor Antagonist |
Mechanism of Action | Histamine H1 Receptor Antagonists |
US Patents and Regulatory Information for ALLEGRA HIVES
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chattem Sanofi | ALLEGRA HIVES | fexofenadine hydrochloride | TABLET;ORAL | 020872-008 | Jan 24, 2011 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Chattem Sanofi | ALLEGRA HIVES | fexofenadine hydrochloride | TABLET;ORAL | 020872-009 | Jan 24, 2011 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ALLEGRA HIVES
International Patents for ALLEGRA HIVES
See the table below for patents covering ALLEGRA HIVES around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Slovenia | 812195 | ⤷ Sign Up | |
Austria | 220667 | ⤷ Sign Up | |
Hungary | 9603167 | ⤷ Sign Up | |
Australia | 7174894 | ⤷ Sign Up | |
Norway | 964859 | ⤷ Sign Up | |
Hong Kong | 1098467 | ⤷ Sign Up | |
Denmark | 0812195 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |